β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

Vancomycin (VAN) is often used to treat methicillin-resistant Staphylococcus aureus (MRSA) bacteremia despite a high incidence of microbiological failure. Recent in vitro analyses of β-lactams in combination with VAN demonstrated synergistic activity against MRSA. The goal of this study was to exami...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dilworth, Thomas J., Ibrahim, Omar, Hall, Pamela, Sliwinski, Jora, Walraven, Carla, Mercier, Renée-Claude
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910806/
https://ncbi.nlm.nih.gov/pubmed/24145519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01204-13
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki